European Society of Cardiology
Skip navigation links
About the ESC
Guidelines & Surveys
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe

Resistant Hypertension Course 

15-16 February 2013, Berlin, Germany. Led by Sverre Kjeldsen and Felix Mahfoud, Chairpersons

Date: 01 Mar 2013
The first Resistant Hypertension Course held in Berlin, Germany, on 15 and 16 February 2013 was organised by Europa Organisation, with the financial support from industry companies. Access the slides

Effective control of blood pressure levels in hypertensive patients is associated with a reduction in cardiovascular mortality and in the incidence of stroke, myocardial infarction and renal events.  Yet, despite the use of combinations of antihypertensive drugs, blood pressure control cannot be obtained in a consistent proportion of patients.

In order to provide resistant hypertensive patients with optimal care, a holistic team approach for the decision-making process and appropriate use of emerging techniques, involving a catheter-based approach is crucial.

What have you found interesting in this meeting?

“The meeting was an excellent meeting because it deals with resistant hypertension and ALL the modalities of treatment…”

Are there further questions you would like to see answered?

“There are so many…and I asked, and I listened to the others asking, so it was a great meeting…”

A joint initiative

 This first Resistant Hypertension Course is a joint initiative, of the European Society of Hypertension (ESH), the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and PCR, aiming to provide a forum for hypertension specialists, physicians caring for hypertensive patients, physicians performing catheter-based interventional medicine and other healthcare providers, to reflect on the current state of knowledge and to share acquired experience.
The Course is also endorsed by the European Society of Cardiology’s Working Group on the Heart and Hypertension, the German Society of Hypertension and the Italian Society of Hypertension

Common objectives

This interactive and practical course is proposed as an open forum, where concerns can be expressed, answers found and consensus reached.

The course’s long-term common objectives are to help physicians across the multiple disciplines that are all focused on the resistant hypertensive patient, uncover the answer to “what is the best management and technical strategy for my patient?” and ensure a successful integration of promising new technologies into their armamentarium.

Our desire is to craft a highly interactive course, developed by physicians for physicians, as well as provide an open forum for learning and exchange, with the following philosophies:

  • At the core of course content and learning outcomes is the patient, as an individual
  • At the heart of education is sharing experience
  • At the source of better patient care is a multidisciplinary team approach
 The Course has gathered 435 participants, in Berlin, Germany, coming from 55 countries around the world. Through reflecting together on knowledge and sharing experience, the Resistant Hypertension Course objectives are to:
  • Better understand what “resistant essential hypertension” is and how a step-by-step logical pathway allows us to confirm this diagnosis and why new treatment options are legitimate;
  • Better apprehend which patients are currently considered as optimal candidates for catheter-based renal sympathetic denervation or other technologies, and what are the current, relative or absolute contraindications;
  • Better recognize what could be the future clinical developments, taking into consideration a precautionary attitude; and
  • Provide a practical overview of current catheter-based renal sympathetic denervation or other available techniques and technologies as well as understand the tips and hints for a successful intervention.

Day 1: ruling out false resistant hypertension, improve the understanding and explore future indications

Patient selection is at the heart of the matter today and, hence, Day 1 of the course, was dedicated to ruling out false resistant hypertension, better understand patient indications, identify non-responder profiles and explore future indications, beyond resistant hypertension, such as heart failure, arrhythmia, sleep apnea or chronic kidney disease.   

This critical subject was presented through multiple adult learning methodologies, from open-minded and interactive discussions with participants around individual patient cases to presentations of clear data-based consensus to expert team consensus or sharing technical experience, with practical tips and hints, around pre-recorded and Live in-a-Box® cases. 

Day 2: baroreflex stimulation and catheter-based renal sympathetic denervation

Day 2 of the course focused on baroreflex stimulation and catheter-based renal sympathetic denervation which have recently been introduced into the European market as new and promising technologies for patients with true treatment-resistant hypertension.

At the present time, five CE-marked renal denervation systems using different treatment strategies are available and many other platforms are currently being tested. The interest in these new technologies is rapidly growing and, in order to provide resistant hypertensive patients with optimal care, a holistic team approach for the decision-making process and appropriate use of the catheter-based technologies are crucial.

"Learning The Techniques" session

The “Learning The Techniques” session provided overviews of each technology in four distinct sections, covering technology rationale, clinical case, clinical data and technical tips and hints, via pre-recorded and Live in-a-Box® cases.

Scientific content now available!

Following a successful foundational Resistant Hypertension Course, the scientific content is now available 

  • Browse by date, speaker or session type
  • Slides packed with educational material can be downloaded in PDF format
  • Videos of each session mean you won’t miss a moment of the programme
  • Examine key topics such as renal denervation, ruling out spurious hypertension causes and innovation 

Save the date!

The second edition of the Resistant Hypertension Course has been announced and will take place 20 to 22 February 2014, in Berlin, Germany

Until the second edition, you can keep in touch with the medical community, interested in the treatment of the resistant hypertensive patient, and find out the latest available educational tools and resources on the RHC Website.